Triana Biomedicines
About:
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Website: https://trianabio.com
Top Investors: RA Capital Management, Lightspeed Venture Partners, Atlas Venture, Surveyor Capital, Logos Capital
Description:
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated the best-in-class platform and initiated multiple programs across different disease areas.
$161M
$1M to $10M
Waltham, Massachusetts, United States
2019-01-01
Jesse Chen, Milind Deshpande, Simon Read
11-50
2022-04-06
Private
© 2025 bioDAO.ai